TI
CALA

Trexquant Investment’s Calithera Biosciences, Inc CALA Stock Holding History

Trexquant Investment’s Portfolio CALA Stock Details CALA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-2,998
Closed -$378K – 1334
2018
Q1 		$378K Buy
2,998
+600
+25% +$93.6K 0.03% 726
2017
Q4 		$400K Buy
2,398
+1,864
+349% +$477K 0.04% 612
2017
Q3 		$168K Buy
+534
New +$168K 0.04% 675
2015
Q4 		– Sell
-1,224
Closed -$132K – 1351
2015
Q3 		$132K Buy
+1,224
New +$159K 0.01% 990

Other funds holding CALA

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Man Group
Man Group London, United Kingdom $55.1B AUM 24.23% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TA
Teachers Advisors New York $81.7B AUM 13.62% 1-Year Est. Return

Trexquant Investment's CALA Position: Q2 2018 in Review

Trexquant Investment sold out of Calithera Biosciences, Inc (CALA) in Q2 2018, closing a stake of 2,998 shares — an estimated $378K sold.

Trexquant Investment first reported a position in CALA in Q3 2015 and held it in 4 quarters. The position peaked at $400K in Q4 2017. 90 funds tracked by Wall St. Rank hold CALA as of Q2 2018.

  • Trexquant Investment reported no remaining Calithera Biosciences, Inc position as of Q2 2018 after selling out during the quarter.
  • Trexquant Investment sold 2,998 Calithera Biosciences, Inc shares in Q2 2018, an estimated $378K.
  • Trexquant Investment first reported a position in Calithera Biosciences, Inc in Q3 2015 and held it in 4 quarters.
  • Trexquant Investment's Calithera Biosciences, Inc position peaked at $400K in Q4 2017.
  • 90 funds tracked by Wall St. Rank held Calithera Biosciences, Inc as of Q2 2018.

Based on Trexquant Investment's 13F filing for Q2 2018, filed 7 Aug 2018.